We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
2
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$46.3M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$30.5M
4
VBIL
Vanguard 0-3 Month Treasury Bill ETF
VBIL
+$29.2M
5
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$24.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBNK
5176
VersaBank
VBNK
$614M
$12 ﹤0.01%
1
-1,851
-100% -$21.4K
EFR
5177
Eaton Vance Senior Floating-Rate Fund
EFR
$319M
$11 ﹤0.01%
1
– –
OILD icon
5178
MicroSectors Oil & Gas Exp. & Prod. -3x Inverse Leveraged ETN
OILD
$33.8M
– –
-75
Closed -$9.07K
RXD icon
5179
ProShares UltraShort Health Care
RXD
$3.04M
$11 ﹤0.01%
+1
New +$24
CTMX icon
5180
CytomX Therapeutics
CTMX
$741M
$10 ﹤0.01%
3
-29,658
-100% -$66.8K
DNP icon
5181
DNP Select Income Fund
DNP
$4.1B
$10 ﹤0.01%
+1
New +$10
MLTX icon
5182
MoonLake Immunotherapeutics
MLTX
$1.45B
$7 ﹤0.01%
1
-273
-100% -$14.2K
YOLO icon
5183
AdvisorShares Pure Cannabis ETF
YOLO
$31.3M
$7 ﹤0.01%
+2
New +$6
MF
5184
MindForge Inc. Class A Ordinary Shares
MF
$18.5M
– –
-39
Closed -$2.76K
AERTW
5185
Aeries Technology Warrant
AERTW
$887K
$6 ﹤0.01%
156
– –
BZFDW icon
5186
BuzzFeed Inc Warrant
BZFDW
$520K
$6 ﹤0.01%
100
– –
GXAI
5187
Gaxos.ai
GXAI
$9.18M
$5 ﹤0.01%
3
-1,678
-100% -$2.48K
SLDPW icon
5188
Solid Power Inc Warrant
SLDPW
$7.3M
$3 ﹤0.01%
+7
New +$4
JSPR icon
5189
Jasper Therapeutics
JSPR
$26.4M
$2 ﹤0.01%
1
-3,746
-100% -$11.4K
UTF.RT
5190
DELISTED
Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025
UTF.RT
$1 ﹤0.01%
+11
New +$1
ABOS icon
5191
Acumen Pharmaceuticals
ABOS
$174M
– –
-3,631
Closed -$4.21K
AC
5192
DELISTED
Associated Capital Group
AC
– –
-164
Closed -$6.15K
ACHV icon
5193
Achieve Life Sciences
ACHV
$688M
– –
-4,586
Closed -$10.4K
ACWX icon
5194
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
– –
-43
Closed -$2.62K
ADSE icon
5195
ADS-TEC Energy
ADSE
$872M
– –
-30
Closed -$414
ADVM
5196
DELISTED
Adverum Biotechnologies
ADVM
– –
-2,137
Closed -$4.59K
AFYA icon
5197
Afya
AFYA
$1.23B
– –
-1,856
Closed -$33.1K
AIFA
5198
All In FutureTech Alliance Inc
AIFA
$14.1M
– –
-17
Closed -$259
AGI icon
5199
Alamos Gold
AGI
$14B
– –
-172
Closed -$4.57K
AGM.A icon
5200
Federal Agricultural Mortgage Class A
AGM.A
– –
-51
Closed -$7.27K
206 207
208
209 210

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.